Insmed Incorporated (INSM) Stock Overview
Explore Insmed Incorporated’s financial performance, market position, analyst ratings, and future outlook.
Insmed Incorporated (INSM)
Key Financials
Key Financials
Market Cap
27.3B
P/E Ratio
-30.51
EPS (TTM)
$-4.11
ROE
-1.11%
INSM Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Insmed Incorporated (NASDAQ: INSM) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Insmed Incorporated's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of INSM on the NASDAQ shows an RSI of 57.66, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $179.56 for the NASDAQ listing.
Key metrics behind Insmed Incorporated's NASDAQ-traded stock include a P/E ratio of -30.51 and a market capitalization of 27.3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of INSM on the NASDAQ.